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Abstract   
 
Background:  Honey is the oldest known wound dressing. Its uses date back to ancient Greece, 
Egypt, and parts of India. Composed of 80% sugar and 17% water, this supersaturated natural 
substance makes a splendid wound dressing. Its high osmolarity, phytochemicals, and enzymatic 
production of hydrogen peroxide inhibit bacterial growth, while its acidic pH and autolytic 
debridement, decrease inflammation and improve blood circulation to enhancing epithelialization 
and healing with minimal scar tissue. The subject of this review is whether studies show that 
honey’s wound healing properties make it a better wound dressing by decreasing the healing 
time of chronic wounds, compared to standard therapy.  
Methods:  An exhaustive search of available medical literature using search engines MEDLINE, 
CHINAHL, and Web of Science was conducted with honey, treatment, therapy, and wounds as 
key words. JADAD score was used to determine the validity of each study.  
Results: Three studies were identified meeting the exclusion and inclusion criteria established. 
All studies were consistent in that honey reduces the healing rate of chronic ulcers but only one 
study reached statistical significance. All studies had weak JADAD scores of three due to their 
lack of blinding the participants. The studies were also of poor quality design in that much of the 
treatment was determined by the clinician and no standard protocol was used across the groups 
tested.   
Conclusion: Honey is an effective wound treatment agent but no additional benefit is gained 
over standard therapy.  
Keywords:  Honey, treatment, therapy, wounds.  
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The Effect of Honey on Treatment for Chronic Wounds Compared to 
Standard Therapy: A Systematic Review 
 
 
 
BACKGROUND 
 
Honey has many purposes in medicine. Historically it has been used to treat coughs, asthma 
symptoms, and even blood pressure.1  Long before the discovery of bacteria, it was considered to 
be the oldest wound dressing2 as it dates back to ancient medical writings of Egypt, Greece and 
parts of India.3,4 Its use on skin wounds has been documented on skin grafts, trauma wounds, 
necrotizing fasciitis, pilonidal sinuses, pressure ulcers, lacerations, burns, surgical wounds, 
herpetic lesions, atopic dermatitis, animal bites, and rheumatoid ulcers.5 The use of honey had 
been forgotten with the discovery of antibiotics however, with antibiotic resistance on the rise in 
recent years, honey has been newly discovered and its uses once again investigated.  
Honey is a natural, sweet substance produced by honey bees of the genera Apis and 
Meliponinae.6 The bees collect nectar from a variety of flowers and process it by adding their 
own body’s enzymes and deposit it into wax cells of the hive where it is concentrated by 
evaporation through fanning of the bees’ wings. The final result is a supersaturated sweetener 
composed of 80% sugar and 17% water. The remainder of the honey is made up of proteins, 
enzymes, and non-essential amino acids.7 The high sugar concentration is primarily composed of 
simple sugars which include 38.2 % fructose and 31.3 % glucose that are readily absorbed by the 
body2 and the other sugars maltose 7.35%, sucrose 1.3% and isomaltose make up the additional 
30%. 8  
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The enzymes found in honey, play an important role in its antibiotic properties. Invertase 
produced by the bee converts sucrose to glucose and fructose, amylase breaks down starch, 
glucose oxidase converts glucose to gluconolactone which in turn yields gluconic acid and 
hydrogen peroxide.4  Trace amounts of vitamin B, calcium, iron, zinc, potassium, phosphorus, 
magnesium, selenium, and chromium are also found in the composition of honey.8 The low pH 
of honey comes from the organic acids acetic, butanoic, formic, citric, succinic, lactic malic, 
pyroglutamic, and gluconic acid.8  
Although the exact composition of honey varies depending on the geographical source and 
the plants on which the bees have been feeding, this supersaturated mixture of sugars with small 
quantities of enzymes, amino acids, vitamins, minerals and organic acids holds many desired 
properties for an impressive antibacterial dressing for wounds.4 Several studies have shown it to 
inhibit over 60 species of bacteria including, anaerobes, gram-positive and gram-negative 
bacteria,9 and even some yeast species of Aspergillus, and Penicillium.2  
The super-saturated solution of honey, containing only 17% water inhibits bacterial growth 
primarily due to this high osmolarity. Water is essential for the survival of bacteria but with a 
low availability the microorganisms cannot survive and reproduce.  When honey is applied to 
wounds, the high solute concentration creates an osmotic effect drawing lymph and other fluid 
out of the wound bed diluting the honey.10 As, the osmolarity decreases by the wound drainage, 
the antibiotic activity is not lost and at times is increased as Sackett11 noted in his study. It is the 
enzymatic effect from glucose oxidase’s production of hydrogen peroxide that brings about the 
continuous additional antimicrobial effect after the sugar saturation is lost. Glucose oxidase 
secreted from the hypopharyngeal glands of the bee,2 converts glucose to gluconic acid and 
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hydrogen peroxide.4 The bactericidal effect of hydrogen peroxide, further decreases the number 
of microorganisms available on the wound bed. The release of hydrogen peroxide is slow and 
continuous for a constant antibacterial effect successfully eliminates microorganisms but is not 
cytotoxic to the surrounding tissue.3,7   
Another factor associated with the antibiotic effect of honey is thought to be due to the 
phytochemicals in the nectar. The phytochemicals found in honey mostly consist of complex 
phenol and organic acids that further serve an antibacterial function.2 They also aid in reducing 
the risk of oxidative damage in the tissue.7 The concentration of phytochemicals varies 
depending on the plant source of the nectar and makes some honey’s more effective than others 
in terms of their antimicrobial activity.  
Cooper et al12 tested three honeys against 17 strains of Pseudomonas Aeruginosa isolated 
from wound patients to compare its antimicrobial effects. They tested Medihoney which works 
primarily using phytochrome as an antibiotic compared to mixed pasture honey which used 
hydrogen peroxide as its antibiotic activity and an artificial honey which uses the high osmolar 
concentration of sugar as an antibiotic source. The results showed no difference in the 
antibacterial effect of the natural honeys with a minimum inhibitory concentration of 6.8-7.5% 
but a significantly higher concentration of 17-22% for artificial sugar is needed to inhibiting all 
17 strains.12 This demonstrates that there is an additional antibiotic characteristic aside from the 
high osmolarity concentration but no difference in effectiveness between the hydrogen peroxide 
over the phytochrome honey.12 
 The third antimicrobial property of honey is due to glucose oxidase converting glucose to 
gluconic acid which gives honey its low pH.4,7 Honey has an acidic composition with a pH 
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between 3.2-4.5, which is acidic enough to inhibit many pathogens.2,5,7 The more acid the pH the 
more the pathogen growth is inhibited.  In addition to decreasing the pathogens in the wound, the 
acidic environment is beneficial to epithelialization. The acid environment increases the amount 
of oxygen released from the hemoglobin in the wound bed, which, in turn, increase the rate of 
granulation.7 
Honey has been shown to microscopically reduce inflammatory cells in acute and chronic 
inflammation. Although its exact mechanism is not understood, it stimulates peripheral blood to 
draw B and T lymphocytes to the surface and activates phagocytes even at honey concentrations 
as low as 0.1%.13 It also stimulates monocytes to release cytokines, Tumor necrosis factor-1, and 
IL 1 and 6.13 Reducing inflammation is very important in wound healing as it improves 
circulation and delivers more oxygen and nutrients to help the tissue repair and heal.5 The anti-
inflammatory effects of honey also reduce the hypertrophic scarring during the maturation phase 
of wound healing resulting in less scar tissue.14 
The high osmolar concentration of honey not only works as an antimicrobial property but 
also as aids in debridement of the wound.  The strong osmotic action draws exudates and lymph 
fluid from the wound out towards the surface to add the moisture needed for autolytic 
debridement.5 This osmotic autolytic debridement, action washes the wound base from beneath 
as it removes debris and sloughs off necrotic tissue that would normally slow down healing 
process.3,8,10 Honey on the wound bed not only draws material out of the wound, but also 
prevents biofilm formation and cross-contamination. It provides a barrier effect on an open 
wound preventing further infection from external contamination.15   
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Honey has a unique feature in that it can reduce and eliminate the malodorous nature of 
wounds. First its antibacterial action against odor producing anaerobes such as bacterioides spp, 
prevotella ssp, peptosterptococcus ssp. destroys the bacteria that typically produces malodor.5 
Secondly, the glucose provided by honey is used by the bacteria, as an alternative to using amino 
acids from the metabolism of serum and dead cells. The end result, is therefore, the production of 
lactic acid, instead of malodorous ammonia, amines, and sulfur compounds which give a wound 
the unpleasant foul smell.3,5 
With the rise in antibiotic resistance the US FDA gave clearance for the use of Medihoney as 
a wound dressing product in 2007.  Medihoney contains Manuka honey from Leptospermum 
scaparium derived from New Zealand tea trees.15  The honey is sterilized with γ radiation to 
remove the spores but retain its biologic properties.3 Manuka honey has a high level of 
phytochemical components and has been found to be very effective in clearing wounds.12 It is 
known that honey’s antibacterial activities are slower than those of traditional antiseptics which 
decrease bacteria count in mere minutes but balancing the speed against honey’s other properties 
is the question and issue here. The subject of this review is whether studies show that its 
combination of longer lasting bactericidal activity, its autolytic debridement activity, moist 
environment formed by the lymph preventing the dressing from adhering to the wound, and the 
sugar content and acidic environment promoting epethelialization through the increased 
availability of oxygen and nutrients to the cells decrease the healing time and make it a better 
wound dressing. 
Many studies have looked at the affects of honey on burns, but few have a primary focus on 
chronic wounds. The focus of this study is to perform a literature search on randomized control 
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trials assessing the healing time of chronic wounds using honey as a wound therapy in 
comparison to standard therapy. Standard therapy for ulcers require debridement of necrotic 
tissue, the use of an occlusive or semipermeable dressings to maintain a moist wound 
environment, and treatment of wound infection if present.16 
 
METHODS 
 
An exhaustive literature search was performed using the search engines MEDLINE, 
CINAHL, and Web of Science databases. Honey, treatment and therapy, and wounds were used 
as the keywords. The results were further limited to English only journals with Medihoney as the 
choice of honey used in treatment. The 239 articles found were read to determine the eligibility 
for the criteria. The inclusion criteria was, all randomized clinical trials, using patients with 
chronic skin wounds who were not receiving treatment with antibiotics, and must have had no 
other comorbidities or poorly controlled diabetes influencing the healing of the wound. Studies 
must have tested Manuka honey in comparison to standard therapy with the primary outcome of 
measuring healing time. Exclusion criteria were articles not in English, not available in full text 
and studies done in-vitro.     
References were evaluated for additional studies that fit the eligible criteria. No articles 
were identified from the references provided.  The JADAD scoring system was used on each trial 
to evaluate the validity of the study, although this was not used as a basis for exclusion.     
RESULTS 
 
 Using the three search engines Medline, CINAHL, and Web of Science, 239 articles were 
identified using the key words honey, therapy, and wounds. Limiting the 239 articles to English 
and studies done on humans left 76 articles to review.  Of those, 34 studies looked at honey on 
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wounds but 16 case reports were excluded leaving 18 articles for screening.  After further 
evaluation of the articles only three studies fit the inclusion and exclusion criteria as randomized 
controlled clinical trials using honey in comparison to standard therapy in patients with chronic 
wounds who had not received antibiotic therapy and had no other comorbidities affecting the 
healing of the wound. The studies are summarized in table 1 and their finding are summarized in 
Table 2.  
 Robson et al4 conducted a open-label randomized clinical trial between September 2004 
and May 2007 with the aim of comparing Medihoney with conventional treatment on wounds 
healing by secondary intention. A total of 105 patients from a large district general hospital in 
the United Kingdom were recruited to participate in the study.  Fifty-two patients were 
randomized to receive 3mm of Medihoney covered with a low adherent dressing and an 
absorbent dressing followed by compression bandage. Fifty-three were randomized to receive 
standard local practice wound care from the hospital’s formulary, leaving the practitioner to 
choose the dressing and compression bandage. The hospital protocol dictated hydrogel be added 
to the wound in the presence of slough or necrotic tissue. Patients were excluded if they had 
diabetes or other health problems, wounds exposing tendons, muscle, or bone, and if they had 
received any antibiotics in the preceding two weeks.  The groups were similarly placed with 
regard to gender, age, size and location of the wound, with 70% of the patients having leg ulcers. 
The median time of complete healing in the honey group was 100 days compared to 140 days in 
the control group with a hazard ratio of 1.3 and 95% CI of 0.77-2.19 and a p-value of 0.321. 
Although the honey showed to be 30% more likely to heal, the wide confidence interval showed 
not to be statistically significant. In the honey treated group, two patients were lost to follow up 
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and eight discontinued interventions mostly due to indications from the clinician. The control 
group had similar results in that one was lost to follow up and 7 discontinued treatment. They 
concluded that healing rates with honey are reduced but the sample size was too small for the 
study to reach statistical significance.4 
 The second study was also an open label randomized clinical trial conducted by Gethin 
and Cowman17 between February 2003 and January 2006. They measured the healing rate at 12 
weeks and the ability of Manuka honey to deslough venous leg ulcers in comparison to standard 
therapy. A total of 108 patients with venous leg ulcers less than 100 mm2 were recruited from 10 
different centers including acute and community hospitals, and vascular and leg clinics. Patients 
were excluded if their Ankle Brachial Pressure Index was ≥ 0.8, if they had poorly controlled 
diabetes, or if they had been taking antibiotics or an immunosuppressant at the time of the study. 
Fifty-four patients were randomized to the honey group and received 5g/20 cm2 of honey weekly 
while 54 patients in the control group received 3 g/20 cm2 weeks followed by compression 
therapy for a total of 4 weeks. Clinical assessment was conducted thereafter on an as needed 
basis which varied from patient to patient, and a final follow up was conducted at 12 weeks. The 
honey group had a median of 34% reduction in wound size at 4 weeks compared to a 13% 
reduction in the control group with a p-value < 0.001. The healing rate at 12 wks was 39% in the 
honey group compared to 33% in the control group with a p-value of 0.03. No patients were lost 
to follow up in either group but 9 withdrew from the honey group and 17 from the control group 
with infection being the number one reason for withdrawal. They concluded that the healing rate 
was significant at 12 weeks for the honey group and had less infection rates compared to 
standard wound therapy.17 
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 The third study was an open-label multicenter randomized controlled trial conducted by 
Jull et al18 In which 368 patients with leg ulcers were recruited from four community based 
nursing services in New Zealand between May 2004 and September 2005. Patients were 
excluded if they had any history of diabetes, rheumatoid arthritis, or peripheral arterial disease. 
Of the study participants, 187 patients were randomized to receive manuka honey impregnated 
into calcium alginate dressings and covered by compression bandage. The honey was changed 
with frequency determined by the clinician. A total of 181 patients were randomized to the 
control group receiving a dressing covered by compression bandage. The dressing of choice was 
decided by the district nurse and consisted of alginate, hydrofibre, hydrocolloid, foam, hydrogel, 
non-adherent, iodine, or silver dressings. Patients in both groups were similar in gender, ABPI, 
and ulcer size at the beginning of the trial. Results showed that at 12 weeks, 104 (55.6 %) ulcers 
had completely healed compared to 90 (49.7%) in the control group giving a 5.9% increase in 
healing (95% CI -4.3 to 15.7, p=0.258). Mean healing time was 63.5 days in the honey group and 
65.3 days in the control group with a difference of -1.8 days (95% CI -7.7 to 4.1 days, p= 0.553). 
In the honey group 32 patients had an infection during the trial compared to 40 in the control 
group giving an absolute decrease of 5.0 (95% CI -3.1 to 13.1, p=0.228), although pain intensity 
was not recorded. Of the patients in the treated group, 47 reported pain compared to 18 in the 
control group with a RR 2.5 (95% CI 1.5 to 4.2, p=0.001). No patients were lost to follow up in 
the honey group and 6 were lost in the control group. However, 31 patients in the honey group 
discontinued their treatment compared to none in the control group mostly due to problems at the 
ulcer site, including, pain, infection, bleeding, and wound deterioration. Jull et al18 concluded 
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that honey did not have a significant enough effect to consider it clinically relevant, and therefore 
there is no additional benefit from using honey impregnated dressings for ulcerations.18    
 
DISCUSSION 
 
The antibacterial, anti-inflammatory, and debridement qualities give honey the potential to be 
a good treatment option for chronic wounds. The objective of this paper was to evaluate the 
healing rate of Manuka honey as a therapy for chronic wounds in comparison to standard 
therapy. The exhaustive systematic review identified three studies that looked at groups of 
patients who participated in randomized clinical trials to receive honey or a hydrogel plus a 
wound dressing. Two of the studies showed to have a small decrease in healing rate in the honey 
treated groups, but the difference was too small and confidence interval too large making the 
results not statistically significant.4,18 The third study showed to have a slight larger difference 
with a statistically significant difference by 6% healing rate with a p value of 0.03.17 However, 
all three studies were poorly conducted with several limitations in the study design. Table 2 
demonstrates each had a weak JADAD score of 3 due to their potential for bias as they were all 
open label studies where none of the participants or the medical professionals was blinded to the 
treatment type and much of the treatment seems to have been left to the individual practitioner’s 
discretion rather than being of standardized design.  
 
Limitations of Study 
 
Robson et al4 in addition to having a small sample size without blinding, did not treat the two 
groups equally. The honey treated group received honey and compression only. In the control 
group, in addition to the initial treatment, as their facility protocol recalled, the patients also 
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received hydrogel only when the presences of slough or necrosis was present on the wound. 
Honey being an autolytic debridement they felt no need to provide additional assistance when 
slough or necrosis was presence.4 The ability of honey to debris the wound is one of its great 
qualities in wound healing. In order to properly assess the superiority over standard treatment the 
groups should have been handles with a standardized protocol.  Due to the lack of blinding, their 
randomization efforts failed, as two of the patients randomized to the honey group did not 
receive honey and 6 of the patients in the control group did not adhere to treatment and received 
honey as a result of patient’s decision from external pressure.4  “Unfortunately, however, because 
of the lack of blinding, a small number of patients allocated to conventional treatment did not 
adhere to treatment and received honey as a result of either patient pressure or external clinical 
decision.”4 Although patients were accounted for based on their assigned group as well as their 
final group and the results were similar, it appears that those conducting the study sabotaged 
their own efforts to some degree to please their patients.  
Gethin and Cowman17 was the only study of the three that showed a statistically significant 
healing rate in the honey treated group, but this study design also lacked the validity of blinding, 
and they failed to recruit the desired number of participants with a total of 108 participants in the 
trial. Of their patients, 24% (n=26) withdrew from the study, six in the honey treated group and 
12 in the control group due to infection at the wound site.17 This is important to note as it is the 
only trial that included patients with diabetes that was well controlled. Although, their diabetes 
was controlled at the start of the trial they did not monitor their diabetes throughout the 12 
weeks. An incidental finding could have been made had they determined if the patients with 
diabetes accounted for the ones that developed the infections but interestingly they do not appear 
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to have followed up on this issue. The other two trails completely excluded patients that had a 
diagnosis of diabetes.4,18 Future studies should place the diabetic population in a separate group 
and monitor their glucose levels throughout the trial.  
Gethin and Cowman17 evaluated their patients on a weekly basis up to 4 weeks and thereafter 
on an as needed basis determined by the health care provider that was not blinded to the 
treatment and a final evaluation at 12 weeks. Not having a standardized follow up protocol 
allowed for extensive variability in the frequency of dressing change. We know that honey’s 
osmotic affect draws lymph fluid to the surface diluting the honey and its antimicrobial 
properties. The other two studies could have potentially also been influenced by the dressing 
frequency change as they do not mention how often the dressings were changed.4,18 The healing 
rate can be affected either by too frequent or too late of a dressing changes. This study was 
terminated at 12 weeks and stopping the trial at this stage fails to demonstrate complete healing 
outcomes.17  
 Jull et al18 included the largest sample size of the three studies with 368 participants 
randomized to receive honey or standard therapy for venous leg ulcers. The study was also an 
open label study failing to blind the patients and involved clinical staff. Another limitation in this 
study is that the control group varied in the “standard” therapy they received. It was left to the 
nurses’ choice to use alginate, hydrofibre, hydrocolloid, foam, hydrogel, non-adherent, iodine, or 
silver dressing. The dressing differed in the absorption and adherence to the wound, which in 
turn could have had a treatment affect influencing the final healing rate of the wound.18 There 
was no standard dressing change for either group, it was left up to the clinical staff to determine 
the type and frequency of dressing change. Due to funding, this study failed to follow all patients 
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to complete healing and also terminated the evaluations at 12 weeks, which has an effect on its 
validity.     
Adverse events 
 
Jull et al18 was the only study that directly evaluated adverse events. The honey group 
had a 17 % (n=31) discontinuation of treatment due to adverse effects of deterioration of the skin 
surrounding the ulcer (n=8), pain (n=4), infection (n=8). The control group had no patients 
discontinue treatment.18 The reason for the difference is not explained but could be related to the 
lack of blinding.  
  Pain and infection were the top two adverse events experienced by the participants in 
both experimental groups of the three studies.4,17,18 Robson et al4 reported one patient (1.9%) in 
the treatment group with pain. The second study by Gethin and Cowman17 reported 6 (11%) 
patients in the treatment group withdrew due to infection at the wound site and 12 (22%) in the 
control group. Jull et al18 reported a higher incidence of pain in the honey group with 47 (25%) 
compared to 18 (10%) in the control group but only 32 (17.1%) compared to 40 (22.1%) in the 
control group reported infection. The difference in infection rate was not significant (p=0.228).18 
It does appear that pain is a problem with the honey protocol but none of the studies measured or 
reported the degree of pain. The pain was likely a result of the acidity of honey and varied 
according to the size of the wound and frequency of application.  
 All three studies proved honey to be an effective wound treatment choice but not a better 
choice for faster healing than standard treatments.4,17,18 Honey showed to cause no harm, and the 
only known adverse event is a variable degree of pain that could be possible reduced by the 
frequency of dressing change. As Robson et al4 demonstrated, honey is a well accepted natural 
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regimen in our society and people are open to the idea of using it as a medical treatment. The 
antimicrobial properties could take honey’s use to a deeper level. Studies have proven honey to 
be sensitive to MRSA and VRE,5,19 without gaining resistance. Blair et al were not successful in 
generating a honey resistant strain of pseudomonas aeruginosa or staph aureus using subleathel 
doses over longer periods of time when Tetracycline, Oxacillin, and Ciprofloxacin were all 
resistant to the pathogens.20 Jull et all18 also looked at the cost effectiveness of using honey. 
When considering nursing, materials, appointments, and hospitalization, there was a -$9.45 (95% 
CI -$39.63 to $16.07) in New Zealand dollars favoring the honey treated group. The difference 
was attributed to only three patients requiring hospitalization for a total of 10 days in the honey 
group compared to 6 patients in the control group hospitalized for a total of 40 days.18   
 
CONCLUSION 
 
There continues to be limited evidence supporting the medical use of honey and the 
studies published are of poor quality. This systematic review evaluated three studies comparing 
sterilized Manuka honey to standard therapy for chronic wounds. All articles had weak validity 
scores using JADAD grading system where none of them receiving more than a three due to the 
potential of biases from the lack of blinding the all participants. The two studies that excluded 
patients with controlled diabetes are consistent in that they demonstrate no additional benefit 
from using honey on the treatment of chronic wounds in comparison to standard therapy. 
However the results were not significant perhaps due to the small population size. All three 
studies are consistent with past studies in demonstrating that honey is effective in treating 
wounds with the only adverse event of pain experienced by the participants.     
21 
 
 Future studies should focus on testing honey on chronic wounds with a better study 
design. The randomized control trial should focus on obtaining a large sample size, double 
blinded participants, and using well developed standard protocol in both groups with same 
treatment in type and frequency of dressing change. Honey should be further investigated as it 
could be the answer to cutting down cost and treating many complicated wounds infected with 
MRSA or VRE and decrease further antibiotic resistance.  
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TABLES 
TABLE1: Summary of Reviewed Studies 
Study Title  Journal/ 
Yr.  
published 
Patients/  
Population 
Intervention Comparison Outcome(s) Study 
type 
Validity 
(JADAD 
score) 
Comments 
Robson, 
Dodd, 
Thomas  
Standardized 
antibacterial 
honey with 
standard 
therapy in 
wound care 
Journal of 
Advanced 
Nursing:  
2008 
Adults with 
wound 
infections 
greater than 12 
wks.  
Manuka 
Honey 
Conventional 
dressing from 
hospital 
protocol 
1. Time for 
complete 
healing of the 
wound.  
2. Time for 
50% reduction 
of the wound 
area.  
RCT 3 (-) Not blinded.  
(-) Pts were 
allowed to switch 
treatment groups.  
  
Gethin, G. 
Cowman, 
S.  
Manuka 
honey vs. 
hydrogel 
Journal of 
Clinical 
Nursing: 
2008 
Adults with 
Venous leg 
ulcers having 
> 50% wound 
area covered in 
Slough 
Manuka 
Honey 
Hydrogel 
Therapy 
Wound size at 
12 weeks 
RCT 3 (-) Not blinded 
(-) Varied in 
frequency of 
dressing change.  
Jull, A. et 
al. 
Randomized 
Clinical trial 
of honey-
impregnated 
dressings for 
venous leg 
ulcers.  
British 
Journal of 
Surgery: 
2008 
Adults with 
leg ulcers.  
Manuka 
Honey 
Nurse 
protocol  
1. Time of 
healing 
2. Wound size 
at 12 
weeks.  
RCT 3 (-) Not blinded.  
(-) No standardized 
protocol for control 
group dressing 
type.  
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TABLE 2: Comparison of Healing Rate of Honey vs. Standard Wound Therapy 
Study Participants 12 week 
healing 
rate 
p-value 12wk 
healing rate 
Mean healing 
time 
p-value 
healing 
time 
Robson, 
Dodd & 
Thomas 
52 Honey 46.2%  100 days 0.321 
53 Control 34.0% 140 days 
Grethin & 
Cowman 
54 Honey 24% 0.03   
54 Control 18%  
Jull et al 187 Honey 55.6% 0.258 63.5 days 0.553 
181 Control 47.9% 65.3 days  
 
